These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 20050329)

  • 1. Cooperative action of CD8 T lymphocytes and natural killer cells controls tumour growth under conditions of restricted T-cell receptor diversity.
    Shanker A; Buferne M; Schmitt-Verhulst AM
    Immunology; 2010 Jan; 129(1):41-54. PubMed ID: 20050329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct patterns of cytolytic T-cell activation by different tumour cells revealed by Ca
    Frick M; Mouchacca P; Verdeil G; Hamon Y; Billaudeau C; Buferne M; Fallet M; Auphan-Anezin N; Schmitt-Verhulst AM; Boyer C
    Immunology; 2017 Feb; 150(2):199-212. PubMed ID: 27716898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Membrane-bound HSP70-engineered myeloma cell-derived exosomes stimulate more efficient CD8(+) CTL- and NK-mediated antitumour immunity than exosomes released from heat-shocked tumour cells expressing cytoplasmic HSP70.
    Xie Y; Bai O; Zhang H; Yuan J; Zong S; Chibbar R; Slattery K; Qureshi M; Wei Y; Deng Y; Xiang J
    J Cell Mol Med; 2010 Nov; 14(11):2655-66. PubMed ID: 19627400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD8 T cell help for innate antitumor immunity.
    Shanker A; Verdeil G; Buferne M; Inderberg-Suso EM; Puthier D; Joly F; Nguyen C; Leserman L; Auphan-Anezin N; Schmitt-Verhulst AM
    J Immunol; 2007 Nov; 179(10):6651-62. PubMed ID: 17982055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reconstitution of CD8+ T cells by retroviral transfer of the TCR alpha beta-chain genes isolated from a clonally expanded P815-infiltrating lymphocyte.
    Tahara H; Fujio K; Araki Y; Setoguchi K; Misaki Y; Kitamura T; Yamamoto K
    J Immunol; 2003 Aug; 171(4):2154-60. PubMed ID: 12902522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytotoxic T lymphocytes to an unmutated tumor rejection antigen P1A: normal development but restrained effector function in vivo.
    Sarma S; Guo Y; Guilloux Y; Lee C; Bai XF; Liu Y
    J Exp Med; 1999 Mar; 189(5):811-20. PubMed ID: 10049945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thymocyte-intrinsic genetic factors influence CD8 T cell lineage commitment and affect selection of a tumor-reactive TCR.
    Shanker A; Auphan-Anezin N; Chomez P; Giraudo L; Van den Eynde B; Schmitt-Verhulst AM
    J Immunol; 2004 Apr; 172(8):5069-77. PubMed ID: 15067090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross-positive selection of thymocytes expressing a single TCR by multiple major histocompatibility complex molecules of both classes: implications for CD4+ versus CD8+ lineage commitment.
    Eshima K; Suzuki H; Shinohara N
    J Immunol; 2006 Feb; 176(3):1628-36. PubMed ID: 16424192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The development and functions of CD4(+) T cells expressing a transgenic TCR specific for an MHC-I-restricted tumor antigenic epitope.
    Han X; Ye P; Luo L; Zheng L; Liu Y; Chen L; Wang S
    Cell Mol Immunol; 2011 Jul; 8(4):333-40. PubMed ID: 21643003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Self-reactive memory-phenotype CD8 T cells exhibit both MHC-restricted and non-MHC-restricted cytotoxicity: a role for the T-cell receptor and natural killer cell receptors.
    Dhanji S; Teh SJ; Oble D; Priatel JJ; Teh HS
    Blood; 2004 Oct; 104(7):2116-23. PubMed ID: 15178577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclophosphamide treatment induces rejection of established P815 mastocytoma by enhancing CD4 priming and intratumoral infiltration of P1E/H-2K(d) -specific CD8+ T cells.
    Rahir G; Wathelet N; Hanoteau A; Henin C; Oldenhove G; Galuppo A; Lanaya H; Colau D; Mackay CR; Van den Eynde B; Moser M
    Int J Cancer; 2014 Jun; 134(12):2841-52. PubMed ID: 24249003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Minimal tolerance to a tumor antigen encoded by a cancer-germline gene.
    Huijbers IJ; Soudja SM; Uyttenhove C; Buferne M; Inderberg-Suso EM; Colau D; Pilotte L; Powis de Tenbossche CG; Chomez P; Brasseur F; Schmitt-Verhulst AM; Van den Eynde BJ
    J Immunol; 2012 Jan; 188(1):111-21. PubMed ID: 22140254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NKT cells provide help for dendritic cell-dependent priming of MHC class I-restricted CD8+ T cells in vivo.
    Stober D; Jomantaite I; Schirmbeck R; Reimann J
    J Immunol; 2003 Mar; 170(5):2540-8. PubMed ID: 12594280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sestrins induce natural killer function in senescent-like CD8
    Pereira BI; De Maeyer RPH; Covre LP; Nehar-Belaid D; Lanna A; Ward S; Marches R; Chambers ES; Gomes DCO; Riddell NE; Maini MK; Teixeira VH; Janes SM; Gilroy DW; Larbi A; Mabbott NA; Ucar D; Kuchel GA; Henson SM; Strid J; Lee JH; Banchereau J; Akbar AN
    Nat Immunol; 2020 Jun; 21(6):684-694. PubMed ID: 32231301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epitope spreading upon P815 tumor rejection triggered by vaccination with the single class I MHC-restricted peptide P1A.
    Markiewicz MA; Fallarino F; Ashikari A; Gajewski TF
    Int Immunol; 2001 May; 13(5):625-32. PubMed ID: 11312250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Engagement of NKG2D by cognate ligand or antibody alone is insufficient to mediate costimulation of human and mouse CD8+ T cells.
    Ehrlich LI; Ogasawara K; Hamerman JA; Takaki R; Zingoni A; Allison JP; Lanier LL
    J Immunol; 2005 Feb; 174(4):1922-31. PubMed ID: 15699119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumour-specific CTL response requiring interactions of four different cell types and recognition of MHC class I and class II restricted tumour antigens.
    Schirrmacher V; Schild HJ; Gückel B; von Hoegen P
    Immunol Cell Biol; 1993 Aug; 71 ( Pt 4)():311-26. PubMed ID: 7901150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor necrosis factor gene-engineered J558 tumor cell-released exosomes stimulate tumor antigen P1A-specific CD8+ CTL responses and antitumor immunity.
    Xie Y; Bai O; Zhang H; Li W; Xiang J
    Cancer Biother Radiopharm; 2010 Feb; 25(1):21-8. PubMed ID: 20187793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The expression of mouse gene P1A in testis does not prevent safe induction of cytolytic T cells against a P1A-encoded tumor antigen.
    Uyttenhove C; Godfraind C; Lethé B; Amar-Costesec A; Renauld JC; Gajewski TF; Duffour MT; Warnier G; Boon T; Van den Eynde BJ
    Int J Cancer; 1997 Jan; 70(3):349-56. PubMed ID: 9033639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumour-experienced T cells promote NK cell activity through trogocytosis of NKG2D and NKp46 ligands.
    Domaica CI; Fuertes MB; Rossi LE; Girart MV; Avila DE; Rabinovich GA; Zwirner NW
    EMBO Rep; 2009 Aug; 10(8):908-15. PubMed ID: 19498463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.